Most Accessed Articles


Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy

, 2018; 13(1): 86-105.

Marco L. Lolli, Stefano Sainas, Agnese C. Pippione, Marta Giorgis, Donatella Boschi and Franco Dosio*


DOI: 10.2174/1574892812666171108124218



Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy

, 2018; 13(1): 2-17.

Sandra Iurescia*, Daniela Fioretti and Monica Rinaldi*


DOI: 10.2174/1574892812666171030163804


Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins

, 2018; 13(2): 184-200.

Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*


DOI: 10.2174/1574892812666171129141211


NLRP3 Inflammasome Activation Inhibitors in Inflammation-Associated Cancer Immunotherapy: An Update on the Recent Patents

, 2018; 13(1): 106-117.

Spandana R. Kopalli , Tae-Bong Kang , Kwang-Ho Lee and Sushruta Koppula*


DOI: 10.2174/1574892812666171027102627



Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied

, 2018; 13(2): 201-208.

Silvia M. Ferrari, Ilaria Ruffilli, Marco Centanni, Camilla Virili, Gabriele Materazzi, Magdalini Alexopoulou, Mario Miccoli, Alessandro Antonelli* and Poupak Fallahi


DOI: 10.2174/1574892813666180220110729



Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature

, 2018; 13(1): 40-69.

Joana B. Sousa, Paula Fresco, Carmen Diniz* and Jorge Goncalves


DOI: 10.2174/1574892812666171108115959



Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science